Integrated Core Strategies (US) LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 4:07 pm Sale | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (US) LLC | 2,031,745 2.500% | -1,420,080 (-41.14%) | Filing |
| 2024-01-17 4:54 pm Purchase | 2024-01-10 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (US) LLC | 3,451,825 5.700% | 3,451,825 (New Position) | Filing |